You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58 - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cyanocobalamin; cyanocobalamin co-57; cyanocobalamin co-58 and what is the scope of freedom to operate?

Cyanocobalamin; cyanocobalamin co-57; cyanocobalamin co-58 is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Clinical Trials: 26
DailyMed Link:CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58 at DailyMed
Recent Clinical Trials for CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação Educacional Serra dos ÓrgãosPhase 4
University of Kansas Medical CenterPhase 2
Tanta UniversityPhase 3

See all CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58 clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58

US Patents and Regulatory Information for CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare DICOPAC KIT cyanocobalamin; cyanocobalamin co-57; cyanocobalamin co-58 N/A;N/A 017406-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58 Market Analysis and Financial Projection Experimental

Cyanocobalamin Market Dynamics and Financial Trajectory

Introduction to Cyanocobalamin

Cyanocobalamin, a synthetic form of vitamin B12, is a crucial nutrient essential for various bodily functions, including the production of red blood cells, nerve function, and DNA synthesis. The market for cyanocobalamin is complex and dynamic, influenced by a variety of factors.

Market Drivers

Rising Aging Population and Vitamin B12 Deficiency

The global population is aging, and this demographic shift is associated with an increase in vitamin B12 deficiency cases. As people age, their ability to absorb vitamin B12 from food sources diminishes, making supplements like cyanocobalamin more necessary[1][4].

Growing Adoption of Plant-Based Diets

The increasing adoption of plant-based diets globally has led to a higher demand for vitamin B12 supplements, as this vitamin is predominantly found in animal products. This trend is particularly significant in regions like North America and Asia, where veganism is on the rise[1][4][5].

Increasing Demand for Functional Foods and Dietary Supplements

There is a growing interest in health and wellness, leading to an increased demand for functional foods and dietary supplements. Cyanocobalamin, being a key component of these products, benefits from this trend[1][4].

Market Restraints

Strict Regulatory Standards

The cyanocobalamin market faces strict regulatory standards, particularly a shift towards natural and organic food sources of vitamin B12. This can make it challenging for synthetic forms like cyanocobalamin to gain approval and consumer trust[1][2].

Competition from Natural Alternatives

Natural alternatives like methylcobalamin pose a significant competition to cyanocobalamin. Consumers often perceive natural vitamins as superior to synthetic ones, affecting market growth[1][2].

Potential Side Effects and Interactions

Cyanocobalamin can have potential side effects and interactions with other medications, which can deter some consumers and healthcare providers from using it[1][2].

Market Opportunities

Technological Advancements in Drug Delivery Systems

Innovations in drug delivery systems, such as oral sprays and dissolvable strips, offer new opportunities for the cyanocobalamin market. These formats can enhance bioavailability and patient compliance[2][4].

Developing Formulations with Added Benefits

Combining cyanocobalamin with other beneficial nutrients or developing bioavailability-enhanced supplements can attract more consumers and differentiate products in a competitive market[1][2].

Sustainability Considerations

Emphasizing sustainability in production, packaging, and distribution can drive competitive differentiation and appeal to the growing number of environmentally conscious consumers[1].

Market Challenges

High Production Costs

The high cost of producing cyanocobalamin is a significant challenge. This can make the product less competitive, especially when compared to natural alternatives or other forms of vitamin B12[4].

Regulatory Hurdles

Navigating regulatory landscapes is crucial but challenging. The market is subject to strict approval processes, which can delay product launches and impact market penetration[1][2].

Financial Trajectory

Current Market Size and Growth Projections

The global cyanocobalamin market was estimated at USD 358.26 million in 2023 and is expected to reach USD 379.29 million in 2024, with a projected growth to USD 543.13 million by 2030 at a CAGR of 6.12%[2].

Regional Insights

North America holds the highest share in the global cyanocobalamin market due to high healthcare expenditure and increasing awareness about vitamins. India and other Asian nations also present significant opportunities due to their large vegetarian populations[2][5].

Segmentation and Distribution Channels

The market is segmented by shape (capsules, powders, liquids, tablets), end-use, and distribution channels. Understanding these segments is crucial for companies to tailor their strategies and product offerings[5].

Cyanocobalamin Co 57: Diagnostic Use

Use in Lactation

Cyanocobalamin Co 57, used as a diagnostic agent, has limited data indicating low excretion into breast milk. However, to minimize radiation exposure to infants, mothers may need to substitute breast milk with previously saved milk for a short period after the diagnostic use[3].

Regional Analysis and Key Players

Global Market Dominance

China dominates the global cyanocobalamin market, accounting for nearly 45% of the market share. It is both the largest producer and consumer, contributing significantly to its GDP[5].

Emerging Markets

India and other Asian nations, along with Africa and the Middle East, represent emerging markets with significant growth potential. However, these regions also face challenges such as misconceptions about veganism and its benefits[4][5].

Key Benefits and Trends

Health Awareness and Urbanization

Rapid urbanization and an increase in disposable income, coupled with growing health awareness, are driving the market growth. The trend towards veganism and the need for fortified foods also contribute to the demand for cyanocobalamin[4][5].

Product Branding and Cost

The market benefits from fewer side effects of cyanocobalamin and the relatively low cost of the product, which enhances its appeal and drives business expansion[5].

Key Takeaways

  • The cyanocobalamin market is driven by an aging population, the adoption of plant-based diets, and increasing demand for functional foods.
  • Strict regulatory standards, competition from natural alternatives, and potential side effects are significant restraints.
  • Innovations in delivery systems, sustainability considerations, and developing formulations with added benefits offer market opportunities.
  • The market is projected to grow at a CAGR of 6.12% to reach USD 543.13 million by 2030.
  • Regional dynamics, particularly in North America and Asia, play a crucial role in market growth.

FAQs

1. What are the primary drivers of the cyanocobalamin market?

The primary drivers include the rising aging population, increasing adoption of plant-based diets, and growing demand for functional foods and dietary supplements[1][4][5].

2. What are the main challenges facing the cyanocobalamin market?

The main challenges include strict regulatory standards, competition from natural alternatives, potential side effects, and high production costs[1][2][4].

3. How is the cyanocobalamin market expected to grow in the future?

The market is expected to grow at a CAGR of 6.12% to reach USD 543.13 million by 2030, driven by technological advancements and increasing health awareness[2].

4. Which regions are expected to drive the growth of the cyanocobalamin market?

North America and Asia, particularly India and China, are expected to drive the growth due to high healthcare expenditure, increasing awareness, and a large vegetarian population[2][5].

5. What role does sustainability play in the cyanocobalamin market?

Sustainability considerations in production, packaging, and distribution can drive competitive differentiation and appeal to environmentally conscious consumers, enhancing market growth[1].

Cited Sources:

  1. Research and Markets: Cyanocobalamin Market Size, Competitors & Forecast to 2030.
  2. 360iResearch: Cyanocobalamin Market by Route of Administration, End-use.
  3. NCBI: Cyanocobalamin Co 57 - Drugs and Lactation Database (LactMed®).
  4. Allied Market Research: Cyanocobalamin Injection Market Size and Growth Analysis By 2030.
  5. Taiwan News: Cyanocobalamin Market 2025 Industry Overview, Key Technology.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.